DICER1 Gene Pleuropulmonary Blastoma NGS Genetic DNA Test
Comprehensive Genetic Testing for Hereditary Cancer Risk
The DICER1 Gene Pleuropulmonary Blastoma NGS Genetic DNA Test represents a significant advancement in personalized medicine and cancer prevention. This specialized genetic analysis focuses on identifying mutations in the DICER1 gene, which plays a crucial role in regulating cell growth and development. When mutations occur in this gene, individuals face an increased susceptibility to developing pleuropulmonary blastoma—a rare childhood lung cancer—along with other tumor types throughout the body.
What Does This Test Measure?
Our advanced Next-Generation Sequencing (NGS) technology provides comprehensive analysis of the DICER1 gene to detect:
- Pathogenic mutations associated with DICER1 syndrome
- Variants of uncertain significance requiring further evaluation
- Specific genetic alterations linked to pleuropulmonary blastoma development
- Inherited mutations that may affect multiple family members
- Novel genetic variants requiring specialized interpretation
Who Should Consider This Test?
This genetic test is particularly recommended for individuals experiencing:
- Personal history of pleuropulmonary blastoma or other DICER1-related tumors
- Family members diagnosed with childhood cancers or rare tumors
- Unexplained developmental abnormalities or cystic lung diseases
- Multiple family members with various tumor types
- Children with suspicious lung lesions or respiratory symptoms
- Individuals with family history of thyroid, kidney, or ovarian tumors
Key Benefits of DICER1 Genetic Testing
Undergoing this comprehensive genetic analysis provides numerous advantages:
- Early Risk Identification: Detect genetic predisposition before symptoms develop
- Personalized Screening: Tailor medical monitoring based on individual risk profile
- Family Planning Guidance: Understand inheritance patterns for future generations
- Proactive Management: Implement preventive measures and early interventions
- Peace of Mind: Reduce uncertainty through definitive genetic information
- Comprehensive Care Coordination: Connect with appropriate specialists for ongoing management
Understanding Your Test Results
Our genetic counseling team provides detailed interpretation of your results:
- Positive Result: Indicates presence of a DICER1 mutation, requiring specialized medical follow-up and family testing
- Negative Result: No mutation detected, though continued medical monitoring may still be recommended
- Variant of Uncertain Significance: Requires additional family studies and ongoing research correlation
- Comprehensive Report: Includes detailed clinical implications and management recommendations
Test Pricing and Details
| Test Component | Price (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified collection centers ensures accessible genetic testing for families nationwide.
Take Control of Your Genetic Health Today
Don’t wait to gain crucial insights into your genetic cancer risk. Our team of genetic counselors and oncology specialists are ready to guide you through the testing process and help interpret your results. Early detection through genetic testing can significantly impact treatment outcomes and family health planning.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your DICER1 Gene Pleuropulmonary Blastoma NGS Genetic DNA Test and take the first step toward proactive cancer prevention and personalized healthcare management.
